Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial

OBJECTIVE: Prostate cancer is a disease of older men. Weekly docetaxel (DPq1w) is often favored over the standard three-weekly regimen (DPq3w) due to concerns about safety and tolerability in this population. MATERIALS AND METHODS: Two subgroup analyses of TAX 327 were conducted. Among patients rece...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Geriatr Oncol
Main Authors: Horgan, Anne M., Seruga, Bostjan, Pond, Greg R., Alibhai, Shabbir M., Amir, Eitan, De Wit, Ronald, Eisenberger, Mario A., Tannock, Ian F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352315/
https://ncbi.nlm.nih.gov/pubmed/24495703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2013.12.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados